Hydroxylamine-induced cleavage of the asparaginyl glycine motif in the production of recombinant proteins: The case of insulin-like growth factor i

Protein Expression and Purification

Volumn 11, Issue 1, 1997, Pages 135-147

  Antorini, Matteo ^a   Breme, Umberto ^a   Caccia, Paolo ^a   Grassi, Cesare ^a   Lebrun, Sylvian ^a   Orsini, Gaetano ^a   Taylor, Geoffrey ^a   Valsasina, Barbara ^a   Marengo, Emilio ^b   Todeschini, Roberto ^c   Andersson, Claes ^a   Gellerfors, Pär ^a   Gustafsson, Jan Gunnar ^a  

^a PFIZER INC   (United States)

^b Talete Srl   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031260312     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1997.0771     Document Type: Article

References (36)

1. 1. Uhlén, M., and Moks, T. (1990) Gene fusion for purpose of expression. An introduction. Methods Enzymol. 185, 129-143.
2. 2. Forsberg, G., Baastrup, B., Rondahl, H., Holmgren, E., Pohl, G., Hartmanis, M., and Lake, M. (1992) An evaluation of different enzymatic cleavage for recombinant fusion proteins, applied on des (1-3) insulin-like growth factor-I. J. Prot. Chem. 11, 201-211.
3. 3. Lundblad, R. L., and Noyes, C. M. (1985) Chemical cleavage of peptide bonds, in "Chemical Reagents for Proteins," pp. 49-53, CRC Press, Boca Raton, FL.
4. 4. Nilsson, B., Forsberg, G., Moks, T., and Hartmanis, M. (1992) Fusion protein in biotechnology and structural biology. Curr. Opin. Struct. Biol. 2, 569-575.
5. 5. Fontana, A., and Gross, E. (1986) Fragmentation of polypeptides by chemical methods, in "Practical Protein Chemistry: A Handbook" (Darbre, A., Ed.), pp. 68-120, Wiley, New York.
6. 6. Gross, E. (1967) The cyanogen bromide reaction. Methods Enzymol. 11, 238-255.
7. 7. Hoppe, J., Weich, H. A., and Eichner, W. (1989) Preparation of biologically active platelet-derived growth factor type BB from a fusion protein expressed in Escherichia coli. Biochemistry 28, 2956-2960.
8. 8. Landon, M. (1977) Cleavage at aspartyl-prolyl bonds. Methods Enzymol. 47, 145-149.
9. 9. Paulsen, J., Ochs, D., Harder, M., Duvos, H., Mayer, H., and Wingender, E. (1995) Large-scale preparation and biological activity of recombinant human parathyroid hormone. J. Biotechnol. 39, 129-136.
10. 10. Bornstein, P., and Balian, G. (1977) Cleavage at Asn-Gly bonds with hydroxylamine. Methods Enzymol. 47, 132-145.
11. 11. Waldenström, M., Holmgren, E., Attersand, A., Kalderén, C., Löenadler, B., Râdén, B., Hansson, L., and Pohl, G. (1991) Synthesis and secretion of a fibrinolytically active tissue-type plasminogen activator variant in Escherichia coli. Gene 99, 243-248.
12. 12. Laron, Z. (1993) Somatomedin-1 (insulin-like growth factor-I) in clinical use. Drugs 45, 1-8.
13. 13. Froesch, E. R., and Hussain, M. (1994) Recombinant human insulin-like growth factor-I. A therapeutic challenge for diabetes mellitus. Diabetologia 37, S179-S185.
14. 14. Gellerfors, P., Axelsson, K., Helander, A., Johansson, S., Kenne, L., Lindqvist, S., Pavlu. B., Skotter, A., and Fryklund, L. (1989) Isolation and characterization of a glycosylated form of human insulin-like growth factor-I produced in Saccharomyces cerevisiae. J. Biol. Chem. 264, 11444-11449.
15. 15. Nilsson, B., Forsberg, G., and Hartmanis, M. (1991) Expression and purification of recombinant insulin-like growth factor-I from Escherichia coli. Methods Enzymol. 198, 3-16.
16. 16. Moks, T., Abrahmsén, L., Österlöf, B., Josephson, S., Östling, M., Enfors, S., Persson, I., Nilsson, B., and Uhlén, M. (1987) Large-scale affinity purification of human insulin-like growth factor-I from culture of Escherichia coli. Biotechnology 5, 379-382.
17. 17. Brem, G., Hartl, P., Besenfelder, U., Wolf, E., Zinovieva, N., and Pfaller, R. (1994) Expression of synthetic cDNA sequences encoding human insulin-like growth factor-I in the mammary gland of transgenic rabbits. Gene 149, 351-355.
18. 18. Samuelsson, E., Wadensten, H., Hartmanis, M., Moks, T., and Uhlén, M. (1991) Facilitate in vitro refolding of human recombinant insulin-like growth factor-I using a solubilizing fusion partner. Biotechnology 9, 363-366.
19. 3, following their expression in Escherichia coli as fusion proteins. J. Mol. Endocrinol. 8, 29-41.
20. 20. Canova-Davis, E., Eng, M., Mukku, V., Reifsnyder, D. H., Olson, C. V., and Ling, V. T. (1992) Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor-I. Biochem. J. 285, 207-213.
21. 21. Forsberg, G., Palm, G., Ekebacke, A., Josephson, S., and Hartmanis, M. (1990) Separation and characterization of modified variants of recombinant human insulin-like growth factor-I derived from a fusion protein secreted from Escherichia coli. Biochem. J. 271, 357-363.
22. 22. Stephenson, R. C., and Clarks, S. (1989) Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J. Biol. Chem. 264, 6164-6170.
23. 23. Nilsson, B., Moks, T., Jansson, B., Abrahmsén, L., Elmblad, A., Holmgren, E., Henrichson, C., Jones, T. A., and Uhlén, M. (1987) A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1, 107-113.
24. 24. Samuelsson, E., Moks, T., Nilsson, B., and Uhlén, M. (1994) Enhanced in vitro refolding of insulin-like growth factor-I using a solubilizing fusion partner. Biochemistry 33, 4207-4211.
25. 25. Stone, K. L., Lo Presti, M. B., Crawford, J. W., De Angelis, R., and Williams, K. R. (1989) Enzymatic digestion of proteins and HPLC peptide isolation, in "A Practical Guide to Protein and Peptide Purification for Microsequencing" (Matsudaira, P. T., Ed.), pp. 31-47, Academic Press, San Diego, CA.
26. 26. Hall, K., Taakano, K., and Fryklund, L. (1974) Radioreceptor assay for Somatomedin, A. J. Clin. Endocrinol. Metab. 39, 973-976.
27. 27. Miller, J. A., Nahri, L. O., Hua, Q., Rosenfeld, R., Arakawa, T., Rohde, M., Prestrelski, S., Lauren, S., Stoney, K. S., Tsai, L., and Weiss, M. A. (1993) Oxidative refolding of insulin-like growth factor-I yields two products of similar thermodynamic stability. A bifurcating protein-folding pathway. Biochemistry 32, 5203-5213.
28. 28. Milner, S. J., Francis, G. L., Wallace, J. C., Magee, B. A., and Ballard, F. J. (1995) Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. Biochem. J. 308, 865-871.
29. 29. Chen, Q., Klemm, N., Duncan, G., and Jeng, I. (1990) Sensitive Benedict test. Analyst 115, 109-115.
30. 30. Tyler-Cross, R., and Schirch, V. (1991) Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. J. Biol. Chem. 266, 22,549-22,556.
31. 31. Wright, H. T. (1991) Sequence and structure determinants of the non-enzymatic deamidation of asparagine and glutamine residues in proteins. Protein Eng. 4, 283-294.
32. 32. Creighton, T. E. (1984) Disulfide bond formation in proteins. Methods Enzymol. 107, 305-329.
33. k-p factorial fractional design. Part I. Technometrics 3, 311-351.
34. k-p fractional factorial. Part II. Technometrics 4, 449-458.
35. 35. Ramachandran, L. K., and Narita, K. (1958) Reactions involving the amide and carboxyl groups of tobacco mosaic virus protein. Biochim. Biophys. Acta 30, 616-624.
36. 36. Milner, S. J., Thomas, S. M., Ballard, F. J., and Francis, G. L. (1996) Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF-I). Biotechnol. Bioengn. 50, 265-272.